Angel Mauricio Castro-Gamero

3PUBLICATIONS

8CO-AUTHORS

ChemotherapyMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 15, 2025

HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases β-catenin levels in glioblastoma cells.

Leilane Sales Oliveira, João Marcos Oliveira-Silva, Hebreia Oliveira Almeida-Souza

|Jan 17, 2025

WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

João Marcos Oliveira-Silva, Leilane Sales Oliveira, Carolina Berraut Chiminazo

|Jan 09, 2025

HDAC6: Tumor Progression and Beyond.

Joao Marcos Oliveira-Silva, Leilane Sales de Oliveira, Joao Vitor Marangoni Taglieri

Pageof 1

Frequent Collaborators

2 joint publications

Alexandre Ferro Aissa

2 joint publications

Graziela Domingues de Almeida Lima

2 joint publications

Marisa Ionta

1 joint publications

João Marcos Oliveira-Silva

1 joint publications

Carlos Vinicius Expedito de Souza

1 joint publications

Hebreia Oliveira Almeida-Souza

1 joint publications

Mario Machado Martins

1 joint publications

Luciana Machado Bastos

Frequent Collaborators

2 joint publications

Alexandre Ferro Aissa

2 joint publications

Graziela Domingues de Almeida Lima

2 joint publications

Marisa Ionta

1 joint publications

João Marcos Oliveira-Silva